APGE · Apogee Therapeutics, Inc.
$134.75
+0.00 (+0.00%)
At close · Aug 21
Going-concern doubt
— cleared Aug 10, 2026
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued. ... Based on the Company's current operating plan, it estimates that its existing cash and cash equivalents of $105.6 million, marketable securities of $866.4 million and long-term marketable securities of $321.9 million as of June 30, 2026, will be sufficient to enable the Company to fund its operating expenses and capital requirements through at least the next 12 months from the issuance of these consolidated financial statements.”View the 10-Q filed Aug 10, 2026
Market Cap
$10.20B
Shares
75.69M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
4,132,507
-2.0% vs reported
Short Squeeze Score
68/100
Short interest 5.6% of shares — P77
Days to cover 4.0 — P59
Price vs VWAP +6.8% — P72
Short-volume trend +5.2% — P71
Short interest change +2.0% — P63
Worst FTD 0.01% of shares — P55
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 4,217,209 | 4,133,296 | +83,913 | 4.03 |
| 2026-07-15 | 4,133,296 | 5,161,455 | -1,028,159 | 2.37 |
| 2026-06-30 | 5,161,455 | 10,477,522 | -5,316,067 | 1.00 |
| 2026-06-15 | 10,477,522 | 10,526,394 | -48,872 | 10.31 |
| 2026-05-29 | 10,526,394 | 9,371,143 | +1,155,251 | 9.36 |
| 2026-05-15 | 9,371,143 | 9,489,537 | -118,394 | 15.85 |
| 2026-04-30 | 9,489,537 | 9,567,729 | -78,192 | 14.29 |
| 2026-04-15 | 9,567,729 | 9,729,380 | -161,651 | 15.53 |
| 2026-03-31 | 9,729,380 | 8,798,347 | +931,033 | 6.07 |
| 2026-03-13 | 8,798,347 | 8,619,325 | +179,022 | 9.96 |
| 2026-02-27 | 8,619,325 | 8,700,530 | -81,205 | 14.11 |
| 2026-02-13 | 8,700,530 | 8,913,346 | -212,816 | 9.06 |
| 2026-01-30 | 8,913,346 | 8,093,742 | +819,604 | 7.41 |
| 2026-01-15 | 8,093,742 | 8,664,816 | -571,074 | 7.79 |
| 2025-12-31 | 8,664,816 | 8,472,837 | +191,979 | 9.02 |
| 2025-12-15 | 8,472,837 | 7,898,663 | +574,174 | 8.84 |
| 2025-11-28 | 7,898,663 | 7,931,680 | -33,017 | 12.98 |
| 2025-11-14 | 7,931,680 | 7,954,445 | -22,765 | 9.93 |
| 2025-10-31 | 7,954,445 | 8,545,761 | -591,316 | 11.22 |
| 2025-10-15 | 8,545,761 | 9,448,327 | -902,566 | 7.95 |
| 2025-09-30 | 9,448,327 | 8,947,262 | +501,065 | 17.17 |
| 2025-09-15 | 8,947,262 | 9,201,255 | -253,993 | 15.75 |
| 2025-08-29 | 9,201,255 | 9,123,436 | +77,819 | 22.97 |
Showing 1–23 of 23 settlements
Key facts
CIK
1974640
CUSIP
03770N101
13F (30d)
272 filings
270 filers
Visit website
Investor relations